894 IS 3-MONTHS POST-TREATMENT RECIST EVALUATION OF BONE METASTASES BY MRI OF THE AXIAL SKELETON (ASMRI) A SURROGATE ENDPOINT FOR PREDICTING OVERALL SURVIVAL (OS) OF PROSTATE CANCER (PCA) PATIENTS?

✍ Scribed by B. Tombal; J.P. Machiels; A. Stainier; B. Vanden Berg; F. Lecouvet

• Book ID: 119621613
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 78 KB
• Volume: 9
• Category: Article
• ISSN: 1569-9056
• DOI: 10.1016/s1569-9056(10)60876-7